Ing Groep Nv Amgen Inc Transaction History

Ing Groep Nv

$16.5 Billion
Q3 2024

A detailed history of Ing Groep Nv transactions in Amgen Inc stock. As of the latest transaction made, Ing Groep Nv holds 294,421 shares of AMGN stock, worth $78.5 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares

294,421

Previous 303,923 3.13%

Holding current value

$78.5 Million

Previous $95 Million 0.1%

% of portfolio

0.57%

Previous 0.58%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$309.38 - $337.38 $2.94 Million - $3.21 Million	-9,502 Reduced 3.13%	294,421 $94.9 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $12.4 Million - $15.1 Million	47,171 Added 18.37%	303,923 $95 Million
Q1 2024 May 10, 2024	SELL	$268.87 - $324.56 $8.56 Million - $10.3 Million	-31,830 Reduced 11.03%	256,752 $73 Million
Q4 2023 Feb 08, 2024	BUY	$255.7 - $288.46 $40.9 Million - $46.1 Million	159,782 Added 124.05%	288,582 $83.1 Million
Q3 2023 Oct 27, 2023	BUY	$218.65 - $271.46 $1.88 Million - $2.34 Million	8,620 Added 7.17%	128,800 $34.6 Million
Q2 2023 Aug 07, 2023	SELL	$214.27 - $253.37 $1.66 Million - $1.96 Million	-7,744 Reduced 6.05%	120,180 $26.7 Million
Q1 2023 May 09, 2023	BUY	$225.79 - $275.2 $16.3 Million - $19.8 Million	72,062 Added 129.0%	127,924 $30.9 Million
Q4 2022 Feb 10, 2023	BUY	$229.03 - $291.01 $1.04 Million - $1.32 Million	4,533 Added 8.83%	55,862 $14.7 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $10.1 Million - $11.4 Million	44,836 Added 690.53%	51,329 $11.6 Million
Q2 2022 Aug 08, 2022	BUY	$230.71 - $256.74 $1.5 Million - $1.67 Million	6,493 New	6,493 $1.58 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $37.8 Million - $41.8 Million	-172,201 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $15.6 Million - $17.8 Million	78,239 Added 83.27%	172,201 $38.7 Million
Q3 2021 Nov 02, 2021	BUY	$212.27 - $248.7 $11.2 Million - $13.1 Million	52,760 Added 128.05%	93,962 $20 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $4.71 Million - $5.23 Million	-20,165 Reduced 32.86%	41,202 $10 Million
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $61,469 - $71,632	-277 Reduced 0.45%	61,367 $15.3 Million
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $5.55 Million - $6.61 Million	25,653 Added 71.28%	61,644 $14.2 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $7.28 Million - $8.09 Million	31,014 Added 623.15%	35,991 $9.15 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $984,500 - $1.21 Million	4,977 New	4,977 $1.17 Million
Q1 2020 May 06, 2020	SELL	$182.24 - $241.7 $7.45 Million - $9.89 Million	-40,905 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$189.21 - $243.2 $27 Million - $34.7 Million	-142,520 Reduced 77.7%	40,905 $9.86 Million
Q3 2019 Nov 08, 2019	BUY	$174.11 - $208.62 $6.39 Million - $7.66 Million	36,725 Added 25.03%	183,425 $35.5 Million
Q2 2019 Aug 12, 2019	BUY	$166.7 - $195.41 $2.41 Million - $2.82 Million	14,439 Added 10.92%	146,700 $27 Million
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $6.27 Million - $7.07 Million	-34,672 Reduced 20.77%	132,261 $25.1 Million
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $98,476 - $114,954	-552 Reduced 0.33%	166,933 $32.5 Million
Q3 2018 Nov 06, 2018	BUY	$185.29 - $208.89 $12.6 Million - $14.2 Million	67,974 Added 68.31%	167,485 $34.7 Million
Q2 2018 Aug 10, 2018	BUY	$166.05 - $186.51 $16.5 Million - $18.6 Million	99,511 New	99,511 $18.4 Million
Q1 2018 May 07, 2018	SELL	$169.43 - $198.0 $28.5 Million - $33.3 Million	-168,273 Closed	0 $0
Q4 2017 Feb 06, 2018	SELL	$168.79 - $188.59 $3.43 Million - $3.83 Million	-20,327 Reduced 10.78%	168,273 $29.3 Million
Q3 2017 Nov 08, 2017	BUY	$167.29 - $191.0 $31.6 Million - $36 Million	188,600	188,600 $35.2 Million

Others Institutions Holding AMGN

# of Institutions

3,126

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $143B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

News

Stay updated on Ing Groep Nv with notifications on news.

Account